Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
A LifeStance Health survey released today finds that the possibility of spontaneous, authentic moments going viral on social media is affecting people's mental well-being and reshaping behavior, self-expression and participation in everyday life.
LifeStance Health Group (LFST) has drawn fresh attention after recent trading left the share price at $11.84, with performance over the past week and month moving in different directions. Short term momentum for LifeStance Health Group has cooled, with a 7 day share price return of down 6.6% and a 30 day share price return of down 3.8%. However, the year to date share price return of 70.1% and 1 year total shareholder return of 118.5% still signal a sharp re-rating as investors reassess both...
The past six months have been a windfall for LifeStance Health Group’s shareholders. The company’s stock price has jumped 92.6%, hitting $12.58 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at LifeStance Health Group (NASDAQ:LFST) and its peers.
Orchestra BioMed received an upgrade from BTIG while LifeStance Health Group received a price target hike from Barclays.
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with th
LifeStance Health Group (LFST) has drawn fresh investor attention after recent trading data showed the stock up over the past month and past 3 months. This move is prompting closer scrutiny of its mental health services business. At a share price of $12.73, LifeStance Health Group has posted a 30 day share price return of 22.76% and a 90 day share price return of 71.79%. The 1 year total shareholder return of 137.06% points to strong recent momentum building from a lower multi year...
LifeStance Health Group has delivered a very strong share price gain over the past year, while its valuation checks send mixed signals. The intrinsic value estimate from a Discounted Cash Flow (DCF) approach points to some upside, yet market multiples suggest the stock screens as expensive and the broader value score is low. Over the past year, LifeStance Health Group has returned about 137%, which puts extra focus on whether recent optimism already prices in much of the story. The long term...
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.